Genetically Modified Mesenchymal Stem Cell Theraopeutic Against Head and Neck Cancer
Clinical trial NCT02079324 · COMPLETED
Trial details
- NCT number
- NCT02079324
- Sponsor
- Genexine, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2016-09-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.